Literature DB >> 20599358

Drug refractoriness of epileptiform activity in organotypic hippocampal slice cultures depends on the mode of provocation.

Abdul Wahab1, Klaus Albus, Uwe Heinemann.   

Abstract

We previously reported that low Mg(2+) or 4-aminopyridine induced seizure-like events in organotypic hippocampal slice cultures (OHSCs) were resistant to standard antiepileptic drugs (Albus et al., 2008). We now show that high-frequency electrical stimulation induced ictal-like afterdischarges in OHSCs are effectively suppressed by the standard antiepileptic drugs phenytoin and carbamazepine. Thus, a single OHSC can express both pharmacoresistant and pharmacosensitive epileptiform activities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599358     DOI: 10.1016/j.eplepsyres.2010.06.007

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  5 in total

1.  An organotypic hippocampal slice culture model of excitotoxic injury induced spontaneous recurrent epileptiform discharges.

Authors:  Julie M Ziobro; Laxmikant S Deshpande; Robert J Delorenzo
Journal:  Brain Res       Date:  2010-11-25       Impact factor: 3.252

2.  DREADDs suppress seizure-like activity in a mouse model of pharmacoresistant epileptic brain tissue.

Authors:  N Avaliani; M Andersson; A H Runegaard; D Woldbye; M Kokaia
Journal:  Gene Ther       Date:  2016-07-14       Impact factor: 5.250

3.  Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus.

Authors:  Karthik Rajasekaran; Marko Todorovic; Jaideep Kapur
Journal:  Ann Neurol       Date:  2012-07       Impact factor: 10.422

Review 4.  Issues related to development of new antiseizure treatments.

Authors:  Karen S Wilcox; Tracy Dixon-Salazar; Graeme J Sills; Elinor Ben-Menachem; H Steve White; Roger J Porter; Marc A Dichter; Solomon L Moshé; Jeffrey L Noebels; Michael D Privitera; Michael A Rogawski
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

Review 5.  Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development.

Authors:  Abdul Wahab
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.